 Pulmonary complications combination therapy cyclophosphamide prednisone Oral cyclophosphamide prednisone standard treatment neoplasms systemic vasculitis frequency idiopathic interstitial lung disease period cases acute respiratory failure Pneumocystis carinii pneumonia PCP patients oral cyclophosphamide prednisone patient polyarteritis nodosa Wegener granulomatosis bronchiolitis obliterans pneumonia chronic lymphocytic leukemia red blood cell aplasia Hypoalbuminemia serum level g/dl daily therapy risk development PCP None patients mm diagnosis negative human immunodeficiency virus Patients oral cyclophosphamide prednisone risk PCP high index suspicion aggressive evaluation opportunistic infection patients consideration trimethoprim-sulfamethoxazole prophylaxis development quantitative measures immunosuppression